Technological Advances in Detecting and Managing Cognitive Impairment in Older Adults: Trends, Challenges, and Future Directions

• URL: http://arxiv.org/abs/2607.28687v1
• Date: Thu, 30 Jul 2026 06:38:33 GMT
• Title: Technological Advances in Detecting and Managing Cognitive Impairment in Older Adults: Trends, Challenges, and Future Directions
• Abstract summary: This article synthesizes recent technological advances for detecting and managing cognitive impairment in older adults.<n>Digital markers are integrated through artificial intelligence (AI), machine learning (ML), and deep learning (DL)<n>The field's near-term promise lies in trustworthy, multimodal, longitudinally validated systems linking early detection to actionable, personalized care.
• Score: 0.0
• License: http://arxiv.org/licenses/nonexclusive-distrib/1.0/
• Abstract: As populations age, cognitive decline from mild cognitive impairment (MCI) to dementia is a defining health challenge of the coming decades, yet routine assessment often misses its earliest signs. This article critically synthesizes recent technological advances for detecting and managing cognitive impairment in older adults, spanning neurophysiological signals (chiefly electroencephalography, EEG), structural and molecular neuroimaging (MRI and amyloid/tau PET), blood-based biomarkers, and digital markers, integrated through artificial intelligence (AI), machine learning (ML), and deep learning (DL). Beyond summarizing, it contributes a cross-disciplinary taxonomy, a methodological-rigor lens foregrounding subject- and site-independent validation, an integrative early-detection framework linking tiered screening to intervention, and comparison tables of detection methods, interventions, and risk and protective factors. EEG markers (alpha/theta changes, P300 latency) and deep models (CNNs, LSTM/BiLSTM, transformers, self-supervised EEG foundation models) report strong accuracy, yet many rest on small, single-site datasets unlikely to survive rigorous external validation. Elsewhere, gains are tangible: plasma p-tau217 has reached clinical utility, with the first blood test cleared to aid Alzheimer's diagnosis in 2025; anti-amyloid therapies (lecanemab, donanemab) are approved despite modest, contested benefits; and multidomain lifestyle prevention has matured. Wearable, remote, speech, and virtual-reality tools enable continuous, ecologically valid monitoring, and multimodal fusion improves sensitivity and specificity. Barriers remain: standardization, explainability, data privacy, and equitable, externally validated deployment. The field's near-term promise lies in trustworthy, multimodal, longitudinally validated systems linking early detection to actionable, personalized care.

Related papers

• Longitudinal Bayesian Learning of Continuous Disease Position across the Alzheimer's Disease Continuum [57.659917052892155]
  We propose a longitudinal Bayesian Learning framework that continuously estimates disease severity from longitudinal diffusion tensor imaging (DTI)<n>Experiments on the Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort demonstrate that DCP consistently outperforms representative disease progression methods.<n>These results suggest that DCS provides a quantitative imaging-derived representation for continuous assessment of Alzheimer's disease progression.
  arXiv  Detail & Related papers  (2026-08-19T20:41:26Z)
• Dementia Etiology Diagnosis via Collaborative Meta Knowledge Enhancement [81.27196033392559]
  We propose a Collaborative Meta Knowledge Enhancement (COME) framework for dementia etiology diagnosis.<n>COME injects multi-center acquisition semantics, source identifiers, and modality indicators as heterogeneity-aware embeddings into a unified Transformer architecture for scale-up training.<n>Our method achieves state-of-the-art in-domain performance with a mean macro-averaged AUC of 85.62% and a 4.29-point gain over the strongest baseline.
  arXiv  Detail & Related papers  (2026-07-24T04:26:47Z)
• Predicting Neuromodulation Outcome for Parkinson's Disease with Generative Virtual Brain Model [95.41752463487008]
  Parkinson's disease affects over ten million people worldwide.<n>Inter-individual variability limits empirical treatment selection, increasing non-negligible surgical risk and cost.<n>We bridge this gap with a pretraining-finetuning framework to predict outcomes directly from resting-state fMRI.
  arXiv  Detail & Related papers  (2026-03-31T02:36:10Z)
• Demographic-Aware Self-Supervised Anomaly Detection Pretraining for Equitable Rare Cardiac Diagnosis [45.00216485193071]
  Rare cardiac anomalies are difficult to detect from electrocardiograms due to their long-tailed distribution.<n>We developed an AI-assisted two-stage ECG framework integrating self-supervised anomaly detection and demographic-aware representation learning.<n>Our method achieves an AUROC of 94.7% for rare anomalies and reduces the common-rare performance gap by 73%.
  arXiv  Detail & Related papers  (2026-03-20T07:04:00Z)
• R-GenIMA: Integrating Neuroimaging and Genetics with Interpretable Multimodal AI for Alzheimer's Disease Progression [63.97617759805451]
  Early detection of Alzheimer's disease requires models capable of integrating macro-scale neuroanatomical alterations with micro-scale genetic susceptibility.<n>We introduce R-GenIMA, an interpretable multimodal large language model that couples a novel ROI-wise vision transformer with genetic prompting.<n>R-GenIMA achieves state-of-the-art performance in four-way classification across normal cognition, subjective memory concerns, mild cognitive impairment, and AD.
  arXiv  Detail & Related papers  (2025-12-22T02:54:10Z)
• A Novel Multimodal Framework for Early Detection of Alzheimers Disease Using Deep Learning [0.0]
  Alzheimers Disease (AD) is a progressive neurodegenerative disorder that poses significant challenges in its early diagnosis.<n>Traditional diagnostic methods fall short of capturing the multifaceted nature of the disease.<n>We propose a novel framework for the early detection of AD that integrates data from three primary sources: MRI imaging, cognitive assessments, and biomarkers.
  arXiv  Detail & Related papers  (2025-08-05T03:46:59Z)
• The Role of AI in Early Detection of Life-Threatening Diseases: A Retinal Imaging Perspective [10.884863227198975]
  We systematically synthesize the latest OCT/A and AO developments, AI/ML approaches, and mHealth/Tele-ophthalmology initiatives.<n>We propose a roadmap for multicenter protocol standardization, prospective validation trials, and seamless incorporation of retinal screening into primary and specialty care pathways.
  arXiv  Detail & Related papers  (2025-05-27T07:19:37Z)
• Federated Anomaly Detection for Early-Stage Diagnosis of Autism Spectrum Disorders using Serious Game Data [0.0]
  This study presents a novel semi-supervised approach for ASD detection using AutoEncoder-based Machine Learning (ML) methods. Our approach utilizes data collected manually through a serious game specifically designed for this purpose. Since the sensitive data collected by the gamified application are susceptible to privacy leakage, we developed a Federated Learning framework.
  arXiv  Detail & Related papers  (2024-10-25T23:00:12Z)
• Addressing the Gaps in Early Dementia Detection: A Path Towards Enhanced Diagnostic Models through Machine Learning [0.0]
  The rapid global aging trend has led to an increase in dementia cases, including Alzheimer's disease. Traditional diagnostic techniques, such as cognitive tests, neuroimaging, and biomarker analysis, face significant limitations in sensitivity, accessibility, and cost. This study explores the potential of machine learning (ML) as a transformative approach to enhance early dementia detection.
  arXiv  Detail & Related papers  (2024-09-05T00:52:59Z)
• Beyond the Eye: A Relational Model for Early Dementia Detection Using Retinal OCTA Images [43.73298205923969]
  We present a novel PolarNet+ that uses retinal optical coherence tomography angiography ( OCTA) to discriminate early-onset Alzheimer's disease (AD) and mild cognitive impairment (MCI) subjects from controls.<n>Our method first maps OCTA images from Cartesian coordinates to polar coordinates, allowing approximate sub-region calculation.<n>We then introduce a multi-view module to serialize and analyze the images along three dimensions for comprehensive, clinically useful information extraction.
  arXiv  Detail & Related papers  (2024-08-09T15:10:34Z)
• An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease [13.213387075528017]
  Alzheimer's disease (AD) is the most prevalent form of dementia worldwide, encompassing a prodromal stage known as Mild Cognitive Impairment (MCI)<n>The objective of the work was to capture structural and functional modulations of brain structure and function relying on multimodal MRI data and Single Nucleotide Polymorphisms.
  arXiv  Detail & Related papers  (2024-06-19T07:31:47Z)
• Current and future roles of artificial intelligence in retinopathy of prematurity [14.333209377077058]
  Retinopathy of prematurity (ROP) is a severe condition affecting premature infants. Recent advancements in deep learning (DL), especially convolutional neural networks (CNNs) have significantly improved ROP detection and classification. The i-ROP deep learning (i-ROP-DL) system also shows promise in detecting plus disease, offering reliable ROP diagnosis potential.
  arXiv  Detail & Related papers  (2024-02-15T14:35:02Z)
• Unsupervised deep learning techniques for powdery mildew recognition based on multispectral imaging [63.62764375279861]
  This paper presents a deep learning approach to automatically recognize powdery mildew on cucumber leaves. We focus on unsupervised deep learning techniques applied to multispectral imaging data. We propose the use of autoencoder architectures to investigate two strategies for disease detection.
  arXiv  Detail & Related papers  (2021-12-20T13:29:13Z)
• Detecting Parkinsonian Tremor from IMU Data Collected In-The-Wild using Deep Multiple-Instance Learning [59.74684475991192]
  Parkinson's Disease (PD) is a slowly evolving neuro-logical disease that affects about 1% of the population above 60 years old. PD symptoms include tremor, rigidity and braykinesia. We present a method for automatically identifying tremorous episodes related to PD, based on IMU signals captured via a smartphone device.
  arXiv  Detail & Related papers  (2020-05-06T09:02:30Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.